The effectiveness of erythromycin in reducing stent-related tissue hyperplasia: An experimental study with a rat esophageal model

Eun Young Kim, Yang Shin Park, Ji Hoon Shin, Young Jun Cho, Dong Ho Shin, Hyun Ki Yoon, Ho Young Song

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Erythromycin is not only a potent antibiotic; it also has effects of reduction of inflammation and suppression of protein synthesis. Purpose: To evaluate the impact of erythromycin on tissue hyperplasia after stent placement in a rat esophageal model. Material and Methods: A total of 21 rats were included. After placement of self-expanding stents in the mid esophagus, the rats were divided into two experimental groups and one control group. The rats in the experimental groups received daily intraperitoneal injections of erythromycin for 5 weeks; 4 mg/kg (group A, n = 7) and 8 mg/kg (group B, n = 7). Those in the control group (n = 7) received 1 mL of saline intraperitoneally. After sacrifice, histologic analysis was done for thickness of the papillary projection, granulation tissue area, percentage of granulation tissue area, and degree of inflammatory cell infiltration. The statistical significance of differences between groups was assessed by Mann-Whitney U test. Results: Tissue hyperplasia as reflected in thickness of papillary projection, granulation tissue area, and percentage of granulation tissue area, was higher in the control group than in the experimental groups, although there was no statistical significance (P = 1.00, 0.332, and 0.263, respectively). However, degree of inflammatory cell infiltration was significantly lower in the experimental groups than the control group (P = 0.025), and the higher dosage of erythromycin reduced inflammatory cell infiltration significantly (P = 0.037). Conclusion: Intraperitoneal administration of erythromycin is very effective in reducing inflammation after stent placement in a rat esophageal model but has no significant effect on granulation tissue formation.

Original languageEnglish
Pages (from-to)868-873
Number of pages6
JournalActa Radiologica
Volume53
Issue number8
DOIs
Publication statusPublished - 2012 Oct 1

Fingerprint

Granulation Tissue
Erythromycin
Hyperplasia
Stents
Control Groups
Inflammation
Nonparametric Statistics
Intraperitoneal Injections
Esophagus
Anti-Bacterial Agents
Proteins

Keywords

  • Erythromycin
  • Esophagus
  • Stent
  • Tissue hyperplasia

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging

Cite this

The effectiveness of erythromycin in reducing stent-related tissue hyperplasia : An experimental study with a rat esophageal model. / Kim, Eun Young; Park, Yang Shin; Shin, Ji Hoon; Cho, Young Jun; Shin, Dong Ho; Yoon, Hyun Ki; Song, Ho Young.

In: Acta Radiologica, Vol. 53, No. 8, 01.10.2012, p. 868-873.

Research output: Contribution to journalArticle

Kim, Eun Young ; Park, Yang Shin ; Shin, Ji Hoon ; Cho, Young Jun ; Shin, Dong Ho ; Yoon, Hyun Ki ; Song, Ho Young. / The effectiveness of erythromycin in reducing stent-related tissue hyperplasia : An experimental study with a rat esophageal model. In: Acta Radiologica. 2012 ; Vol. 53, No. 8. pp. 868-873.
@article{957d52ea70044d7faa48dd03491f6f01,
title = "The effectiveness of erythromycin in reducing stent-related tissue hyperplasia: An experimental study with a rat esophageal model",
abstract = "Background: Erythromycin is not only a potent antibiotic; it also has effects of reduction of inflammation and suppression of protein synthesis. Purpose: To evaluate the impact of erythromycin on tissue hyperplasia after stent placement in a rat esophageal model. Material and Methods: A total of 21 rats were included. After placement of self-expanding stents in the mid esophagus, the rats were divided into two experimental groups and one control group. The rats in the experimental groups received daily intraperitoneal injections of erythromycin for 5 weeks; 4 mg/kg (group A, n = 7) and 8 mg/kg (group B, n = 7). Those in the control group (n = 7) received 1 mL of saline intraperitoneally. After sacrifice, histologic analysis was done for thickness of the papillary projection, granulation tissue area, percentage of granulation tissue area, and degree of inflammatory cell infiltration. The statistical significance of differences between groups was assessed by Mann-Whitney U test. Results: Tissue hyperplasia as reflected in thickness of papillary projection, granulation tissue area, and percentage of granulation tissue area, was higher in the control group than in the experimental groups, although there was no statistical significance (P = 1.00, 0.332, and 0.263, respectively). However, degree of inflammatory cell infiltration was significantly lower in the experimental groups than the control group (P = 0.025), and the higher dosage of erythromycin reduced inflammatory cell infiltration significantly (P = 0.037). Conclusion: Intraperitoneal administration of erythromycin is very effective in reducing inflammation after stent placement in a rat esophageal model but has no significant effect on granulation tissue formation.",
keywords = "Erythromycin, Esophagus, Stent, Tissue hyperplasia",
author = "Kim, {Eun Young} and Park, {Yang Shin} and Shin, {Ji Hoon} and Cho, {Young Jun} and Shin, {Dong Ho} and Yoon, {Hyun Ki} and Song, {Ho Young}",
year = "2012",
month = "10",
day = "1",
doi = "10.1258/ar.2012.120351",
language = "English",
volume = "53",
pages = "868--873",
journal = "Acta Radiologica",
issn = "0284-1851",
publisher = "SAGE Publications Ltd",
number = "8",

}

TY - JOUR

T1 - The effectiveness of erythromycin in reducing stent-related tissue hyperplasia

T2 - An experimental study with a rat esophageal model

AU - Kim, Eun Young

AU - Park, Yang Shin

AU - Shin, Ji Hoon

AU - Cho, Young Jun

AU - Shin, Dong Ho

AU - Yoon, Hyun Ki

AU - Song, Ho Young

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Background: Erythromycin is not only a potent antibiotic; it also has effects of reduction of inflammation and suppression of protein synthesis. Purpose: To evaluate the impact of erythromycin on tissue hyperplasia after stent placement in a rat esophageal model. Material and Methods: A total of 21 rats were included. After placement of self-expanding stents in the mid esophagus, the rats were divided into two experimental groups and one control group. The rats in the experimental groups received daily intraperitoneal injections of erythromycin for 5 weeks; 4 mg/kg (group A, n = 7) and 8 mg/kg (group B, n = 7). Those in the control group (n = 7) received 1 mL of saline intraperitoneally. After sacrifice, histologic analysis was done for thickness of the papillary projection, granulation tissue area, percentage of granulation tissue area, and degree of inflammatory cell infiltration. The statistical significance of differences between groups was assessed by Mann-Whitney U test. Results: Tissue hyperplasia as reflected in thickness of papillary projection, granulation tissue area, and percentage of granulation tissue area, was higher in the control group than in the experimental groups, although there was no statistical significance (P = 1.00, 0.332, and 0.263, respectively). However, degree of inflammatory cell infiltration was significantly lower in the experimental groups than the control group (P = 0.025), and the higher dosage of erythromycin reduced inflammatory cell infiltration significantly (P = 0.037). Conclusion: Intraperitoneal administration of erythromycin is very effective in reducing inflammation after stent placement in a rat esophageal model but has no significant effect on granulation tissue formation.

AB - Background: Erythromycin is not only a potent antibiotic; it also has effects of reduction of inflammation and suppression of protein synthesis. Purpose: To evaluate the impact of erythromycin on tissue hyperplasia after stent placement in a rat esophageal model. Material and Methods: A total of 21 rats were included. After placement of self-expanding stents in the mid esophagus, the rats were divided into two experimental groups and one control group. The rats in the experimental groups received daily intraperitoneal injections of erythromycin for 5 weeks; 4 mg/kg (group A, n = 7) and 8 mg/kg (group B, n = 7). Those in the control group (n = 7) received 1 mL of saline intraperitoneally. After sacrifice, histologic analysis was done for thickness of the papillary projection, granulation tissue area, percentage of granulation tissue area, and degree of inflammatory cell infiltration. The statistical significance of differences between groups was assessed by Mann-Whitney U test. Results: Tissue hyperplasia as reflected in thickness of papillary projection, granulation tissue area, and percentage of granulation tissue area, was higher in the control group than in the experimental groups, although there was no statistical significance (P = 1.00, 0.332, and 0.263, respectively). However, degree of inflammatory cell infiltration was significantly lower in the experimental groups than the control group (P = 0.025), and the higher dosage of erythromycin reduced inflammatory cell infiltration significantly (P = 0.037). Conclusion: Intraperitoneal administration of erythromycin is very effective in reducing inflammation after stent placement in a rat esophageal model but has no significant effect on granulation tissue formation.

KW - Erythromycin

KW - Esophagus

KW - Stent

KW - Tissue hyperplasia

UR - http://www.scopus.com/inward/record.url?scp=84867704578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867704578&partnerID=8YFLogxK

U2 - 10.1258/ar.2012.120351

DO - 10.1258/ar.2012.120351

M3 - Article

C2 - 22855416

AN - SCOPUS:84867704578

VL - 53

SP - 868

EP - 873

JO - Acta Radiologica

JF - Acta Radiologica

SN - 0284-1851

IS - 8

ER -